Market News AIOpen the app

TRAX stock news · First Tracks Biotherapeutics, Inc.

Stories about First Tracks Biotherapeutics, Inc. (TRAX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for TRAX

Follow First Tracks Biotherapeutics, Inc. (TRAX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TRAX
Free on the App Store and Google Play, or on the web.
  1. Oct 15, 2026, 4:39 PM ET · Market

    First Tracks Biotherapeutics, Inc. has agreed to sell about 6.1 million shares for $32.75 each.

    Neutral

    First Tracks agreed to raise about $200 million by issuing 6.1 million shares. The cash and added shares pull in opposite directions, so the deal does not clearly change its outlook.

  2. Oct 13, 2026, 9:00 AM ET · Market

    First Tracks Biotherapeutics, Inc. shares good news about a study for ANB033 in Celiac Disease.

    Good for TRAX

    First Tracks Biotherapeutics reported positive early study results for ANB033 in celiac disease. This supports the company, though the report covers only the first study group.

  3. Oct 12, 2026, 10:05 AM ET · Market

    Big stocks like First Tracks Biotherapeutics, C3.ai, and CCC Intelligent Solutions jumped up on Monday.

    Good for TRAX

    First Tracks Biotherapeutics reported that ANB033 protected the gut during a 14-day gluten challenge. The early results favor the company, but do not show lasting benefit.

  4. Oct 12, 2026, 8:17 AM ET · Market

    12 health care companies are changing prices before the market opens on Monday.

    Neutral

    First Tracks shares rose about 15% before Monday's open, but the article gives no business reason, so its outlook is unchanged.